NOVEL USE OF 1-[4-(5-CYANOINDOL-3-YL)BUTYL]-4-(2-CARBAMOYL-BENZOFURAN-5-YL)-PIPERAZINE AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS FOR THE TREATMENT OF BIPOLAR DISORDERS AND MANIA
Use of 1-(4-(5-cyanoindol-3-yl)butyl)-4-(2-carbamoyl-benzofuran-5-yl)-piperazine or its physiologically acceptable salts for the manufacture of medicaments for the treatment of sub-type anxiety disorders, is new. Use of 1-(4-(5-cyanoindol-3-yl)butyl)-4-(2-carbamoyl-benzofuran-5-yl)-piperazine or its physiologically acceptable salts for the manufacture of medicaments for the treatment of sub-type anxiety disorders chosen from the sub-types panic disorder with or without agoraphobia, agoraphobia, obsessive-compulsive spectrum disorders, social phobia, post-traumatic stress disorder, acute stress indication and/or generalized anxiety disorder. ACTIVITY : Tranquilizer； nootropic； antimanic； antiaddictive； anorectic. No biological data is given. MECHANISM OF ACTION : Selective serotonin reuptake inhibitor； 5-HT 1A-receptor agonist.
